Finance

Lists
Why is BAYZF down 3.90%?
Dive Deeper
BAYZF:OTCMKTS
Bayer AG
$ 55.35
-3.90%
(-2.25) 1D
9-р сарын 29, 14:47:40 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BAYZF...
Open
$ 55.35
High
$ 55.35
Low
$ 55.35
Mkt. cap
54.47 тэрбум
Avg. vol.
3.54 мян
Volume
1.20 мян
52-wk high
$ 61.38
52-wk low
$ 30.13
Beta
0.54
Shares outstanding
982.42 сая
No. of employees
88 мян
Open
$ 55.35
High
$ 55.35
Low
$ 55.35
Mkt. cap
54.47 тэрбум
Avg. vol.
3.54 мян
Volume
1.20 мян
52-wk high
$ 61.38
52-wk low
$ 30.13
Beta
0.54
Shares outstanding
982.42 сая
No. of employees
88 мян
News stories
From web sources and news partners
Profile
Bayer AG is a German multinational pharmaceutical and biotechnology company and is one of the largest pharmaceutical companies and biomedical companies in the world. Headquartered in Leverkusen, Bayer's areas of business include pharmaceuticals, consumer healthcare products, agricultural chemicals, seeds and biotechnology products. The company is a component of the EURO STOXX 50 stock market index. Bayer was founded in 1863 in Barmen as a partnership between dye salesman Friedrich Bayer and dyer Johann Friedrich Weskott. The company was established as a dyestuffs producer, but the versatility of aniline chemistry led Bayer to expand its business into other areas. In 1899, Bayer launched the compound acetylsalicylic acid under the trademarked name Aspirin. Aspirin is on the World Health Organization's List of Essential Medicines. In 2021, it was the 34th most commonly prescribed medication in the United States, with more than 17 million prescriptions. In 1904, Bayer received a trademark for the "Bayer Cross" logo, which was, from 1910, subsequently stamped onto each aspirin tablet, creating an enduring brand image. Wikipedia
About Bayer AG
CEOBill Anderson
Employees87.8 мян
Founded1863 оны 8-р сарын 1
Headquarters-
SectorPharmaceutical industry
Websitebayer.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
9.66 тэрбум
11.44 тэрбум
13.40 тэрбум
10.87 тэрбум
Cost of goods sold
4.31 тэрбум
4.23 тэрбум
5.23 тэрбум
4.52 тэрбум
Cost of revenue
4.31 тэрбум
4.23 тэрбум
5.23 тэрбум
4.52 тэрбум
Research and development expenses
1.50 тэрбум
1.29 тэрбум
1.42 тэрбум
1.51 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.40 тэрбум
5.37 тэрбум
3.70 тэрбум
3.94 тэрбум
Operating expense
5.90 тэрбум
3.89 тэрбум
4.64 тэрбум
5.35 тэрбум
Total operating expenses
10.20 тэрбум
8.12 тэрбум
9.88 тэрбум
9.87 тэрбум
Operating income
-543.00 сая
3.32 тэрбум
3.53 тэрбум
999.00 сая
Other non operating income
-7.00 сая
1.51 тэрбум
-55.00 сая
-329.00 сая
EBT including unusual items
-1.16 тэрбум
-3.37 тэрбум
2.99 тэрбум
321.00 сая
EBT excluding unusual items
-1.16 тэрбум
4.63 тэрбум
2.99 тэрбум
502.00 сая
Income tax expense
-202.00 сая
378.00 сая
222.00 сая
92.00 сая
Effective tax rate
17.40%
-11.21%
7.43%
28.66%
Other operating expenses
993.00 сая
-2.76 тэрбум
-470.00 сая
-97.00 сая
Net income
-963.00 сая
-3.76 тэрбум
2.76 тэрбум
219.00 сая
Net profit margin
-9.97%
-32.85%
20.61%
2.01%
Earnings per share
0.57
-
-
-
Interest and investment income
-
471.00 сая
-
-
Interest expense
-539.00 сая
-527.00 сая
-474.00 сая
-81.00 сая
Net interest expenses
-539.00 сая
-56.00 сая
-474.00 сая
-81.00 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
412.00 сая
4.72 тэрбум
4.76 тэрбум
2.16 тэрбум
Gain or loss from assets sale
-33.00 сая
-191.00 сая
-161.00 сая
-14.00 сая
AI content may include mistakes. Learn more
Google аппс